Production of China’s Sinopharm vaccine in Hungary’s soon-to-be-built vaccine factory is ‘unjustified,’ according to renowned virologist, Ernő Duda. Hungary should take on the production of state-of-the-art mRNA vaccines instead, University of Szeged’s professor emeritus says.
Duda’s criticism came in the wake of news that in addition to its own coronavirus vaccine that is being developed at the moment (which is similarly based on inactivated/killed virus technology), Hungary’s vaccine plant will also produce China’s Sinopharm vaccines.
From a professional point of view, Sinopharm is definitely less useful and more primitive than the mRNA vaccines, Duda told RTL Klub. According to him, mRNA vaccine production would be a lot more advantageous for Hungary in the long run, as they could be used not only against Covid but against other viruses too with some modifications.
“It is not clear to me why we are not trying to use state-of-the-art technology, especially if it is related to Hungarians,” Duda said, in reference to Hungarian researchers Katalin Karikó and Norbert Pardi, who both played indispensable roles in the development of Pfizer/BioNTech’s vaccine.
The Ministry for Innovation and Technology told RTL Klub that multiple types of vaccines will be produced in the plant where professional preparations are still ongoing.
featured image illustration via Attila Balázs/MTI